mhurhangee/patent-ind-claim-en huggingface dataset:
A phase-change heat exchanger, comprising a heat exchange core, wherein the heat exchange core comprises an evaporator and a condenser which is in communication with the evaporator and is located above the evaporator , wherein a preset obtuse angle is formed between the evaporator and the condenser , characterised in that the phase-change heat exchange further comprises a housing , and in that a separation plate is provided in the housing , an inner chamber of the housing is separated by the separation plate into an inner circulation heat exchange chamber and an outer circulation heat exchange chamber that are not in communication with each other, the heat exchange core is mounted in the inner chamber of the housing, the evaporator of the heat exchange core is located in the inner circulation heat exchange chamber , and the condenser of the heat exchange core is located in the outer circulation heat exchange chamber , wherein the inner circulation heat exchange chamber and the outer circulation heat exchange chamber are arranged sequentially from bottom to top, and the evaporator is vertically arranged in the inner circulation heat exchange chamber or the condenser is vertically arranged in the outer circulation heat exchange chamber . wherein the heat exchange core comprises an evaporator and a condenser which is in communication with the evaporator and is located above the evaporator , wherein a preset obtuse angle is formed between the evaporator and the condenser , characterised in that the phase-change heat exchange further comprises a housing , and in that a separation plate is provided in the housing , an inner chamber of the housing is separated by the separation plate into an inner circulation heat exchange chamber and an outer circulation heat exchange chamber that are not in communication with each other, the heat exchange core is mounted in the inner chamber of the housing, the evaporator of the heat exchange core is located in the inner circulation heat exchange chamber , and the condenser of the heat exchange core is located in the outer circulation heat exchange chamber , wherein the inner circulation heat exchange chamber and the outer circulation heat exchange chamber are arranged sequentially from bottom to top, and the evaporator is vertically arranged in the inner circulation heat exchange chamber or the condenser is vertically arranged in the outer circulation heat exchange chamber .
An absorbent article comprising an absorbent core; wherein the absorbent core comprises a superabsorbent polymer material and a superabsorbent polymer immobilizing material; wherein the superabsorbent polymer immobilizing material comprises from 20% to 70% of a first polymer, by weight of the superabsorbent polymer immobilizing material; wherein the superabsorbent polymer immobilizing material comprises from 30% to 80% of a second polymer, by weight of the superabsorbent polymer immobilizing material; wherein the first polymer has a peak molecular weight of from 65,000 g/mol to 700,000 g/mol, according to the Peak Molecular Weight Test Method described herein; wherein the first polymer is a random and/or block copolymer having ethylene derived units and/or C3-C10 alpha olefin derived units, or the first polymer is a polyolefinic homopolymer having ethylene derived units or propylene derived units or 1-butene derived units, or the first polymer is a styrenic block copolymer; wherein the second polymer has a peak molecular weight of from 1,000 g/mol to 60,000 g/mol, according to the Peak Molecular Weight Test Method described herein; wherein the second polymer is a polyolefin; wherein the superabsorbent polymer immobilizing material has a Shear Viscosity at 10 (1/s) at 230 °C of from 300 mPa·s to 10,000 mPa·s, according to the Viscosity Rheometry Test Method described herein; and wherein the superabsorbent polymer immobilizing material is substantially free of a tackifier. wherein the absorbent core comprises a superabsorbent polymer material and a superabsorbent polymer immobilizing material; wherein the superabsorbent polymer immobilizing material comprises from 20% to 70% of a first polymer, by weight of the superabsorbent polymer immobilizing material; wherein the superabsorbent polymer immobilizing material comprises from 30% to 80% of a second polymer, by weight of the superabsorbent polymer immobilizing material; wherein the first polymer has a peak molecular weight of from 65,000 g/mol to 700,000 g/mol, according to the Peak Molecular Weight Test Method described herein; wherein the first polymer is a random and/or block copolymer having ethylene derived units and/or C3-C10 alpha olefin derived units, or the first polymer is a polyolefinic homopolymer having ethylene derived units or propylene derived units or 1-butene derived units, or the first polymer is a styrenic block copolymer; wherein the second polymer has a peak molecular weight of from 1,000 g/mol to 60,000 g/mol, according to the Peak Molecular Weight Test Method described herein; wherein the second polymer is a polyolefin; wherein the superabsorbent polymer immobilizing material has a Shear Viscosity at 10 (1/s) at 230 °C of from 300 mPa·s to 10,000 mPa·s, according to the Viscosity Rheometry Test Method described herein; and wherein the superabsorbent polymer immobilizing material is substantially free of a tackifier.
A polymeric composition, comprising a poly(ethylene glycol), a viscoelastic polymer, that is hyaluronic acid, an initiator for promoting polymerisation of the poly(ethylene glycol) and the viscoelastic polymer, and an antioxidant which is trehalose, wherein, in polymerized form, the composition has a refractive index, measured according to the method disclosed in the experimental part of this specification, of 1.30 to 1.40, wherein the initiator is a photo initiator which is a combination of eosin Y, triethanolamine and N-vinyl-2-pyrrolidinone and wherein the poly(ethylene glycol) is poly(ethylene glycol) diacrylate.
An information processing method comprising controlling, by an information processing apparatus , execution of a function of a program subject to a maintenance license on a basis of a result of comparison between a valid period of the maintenance license based on maintenance license data stored in the information processing apparatus and a release time of the program stored in the program.
Sample designed for measuring particles with a housing having an upper and a lower side through which at least one continuous opening extends, and at least one glass substrate with markings for focusing a microscope, wherein the glass substrate is accommodated in the opening , wherein the markings are applied by means of a lithographic process and have no indentations. a housing having an upper and a lower side through which at least one continuous opening extends, and at least one glass substrate with markings for focusing a microscope, wherein the glass substrate is accommodated in the opening , wherein the markings are applied by means of a lithographic process and have no indentations.
An ex vivo or in vitro method for identifying functional targets of an RNA binding polypeptide in a transcriptome of a cell, the method comprising (a) contacting the transcriptome with a fusion polypeptide, the fusion polypeptide comprising the RNA binding polypeptide operatively linked to the catalytic domain of an RNA editing enzyme, wherein the RNA editing enzyme is ADAR2 comprising mutations E488Q, V493A, and/or T490A; and (b) detecting novel RNA editing events in the transcriptome. (a) contacting the transcriptome with a fusion polypeptide, the fusion polypeptide comprising the RNA binding polypeptide operatively linked to the catalytic domain of an RNA editing enzyme, wherein the RNA editing enzyme is ADAR2 comprising mutations E488Q, V493A, and/or T490A; and (b) detecting novel RNA editing events in the transcriptome.
A mesenchymal stem cell composition for use in treating in a canine or feline patient a preselected disease or diseased state selected from: degenerative bone disease, osteoarthritis, rheumatoid arthritis, polyarthritis, systemic lupus erythematosus, inflammatory bowel disease, atopy, hepatitis, chronic steroid responsive meningitis-arteritis, beagle pain syndrome, chronic renal failure disease, keratoconjunctivitis sicca, immune mediated non-erosive arthritis, immune mediated hemolytic anemia, immune mediated thrombocytopenia, Evans syndrome, intervertebral disc disease, refractory corneal ulcer, diabetes mellitus, eosinophilic granuloma complex, cholangitis, exercise induced pulmonary hemorrhage, rhabdomyolysis, corneal ulcer, eczema, multiple sclerosis, muscular dystrophy, and muscle fibrosis secondary to disease or trauma, wherein the treatment comprises the step of systemically administering a therapeutic dose of a mesenchymal stem cell composition through an intravenous injection, the mesenchymal stem cell composition comprising mesenchymal stem cells harvested from at least one tissue selected from the group consisting of testicle tissue and uterine tissue, wherein the mesenchymal stem cell composition comprises a solution having a concentration of approximately 2,000,000 cells or less per mL of solution, wherein the mesenchymal stem cells are allogeneic or autologous to the patient. degenerative bone disease, osteoarthritis, rheumatoid arthritis, polyarthritis, systemic lupus erythematosus, inflammatory bowel disease, atopy, hepatitis, chronic steroid responsive meningitis-arteritis, beagle pain syndrome, chronic renal failure disease, keratoconjunctivitis sicca, immune mediated non-erosive arthritis, immune mediated hemolytic anemia, immune mediated thrombocytopenia, Evans syndrome, intervertebral disc disease, refractory corneal ulcer, diabetes mellitus, eosinophilic granuloma complex, cholangitis, exercise induced pulmonary hemorrhage, rhabdomyolysis, corneal ulcer, eczema, multiple sclerosis, muscular dystrophy, and muscle fibrosis secondary to disease or trauma, wherein the treatment comprises the step of systemically administering a therapeutic dose of a mesenchymal stem cell composition through an intravenous injection, the mesenchymal stem cell composition comprising mesenchymal stem cells harvested from at least one tissue selected from the group consisting of testicle tissue and uterine tissue, wherein the mesenchymal stem cell composition comprises a solution having a concentration of approximately 2,000,000 cells or less per mL of solution, wherein the mesenchymal stem cells are allogeneic or autologous to the patient.
A mixture containing a fluorine-free cationic CMR-free polyurethane dispersion and a fluorine-free wax and/or paraffin dispersion for the hydrophobization, especially for the impregnation and/or coating, of textile fabric sheets, wherein said polyurethane is prepared by the reaction of one or more hydrophobic polymeric diols having an average molecular weight of from 1000 to 5000 g/mol and one or more tertiary amino compounds containing hydroxy groups, one or more diisocyanates, with or without adding solvents, and transferring the polymeric reaction product obtained into water using a volatile acid and suitable emulsifying agents.
A method for making an alcoholic spirit using a fermentation process of strawberries, after they are washed and pulped, with the addition of Saccharomyces cerevisiae galactose - fungus (0.8 g/L).
A robot cell comprising: a first surface part on which a robot that is configured to perform a work by performing a predetermined operation is arranged; a second surface part in which a plurality of fixing portions that are used to fix a working unit used in the work by the robot are provided at predetermined positions, and to which the working unit is fixed by using one or more fixing portions selected from the fixing portions , wherein the robot is configured to perform the work by using the working unit fixed to the second surface part and includes a sensor configured to detect a predetermined position of the second surface part , which position is associated with the plurality of fixing portions , and to perform the predetermined operation by using the detected predetermined position as a reference, the second surface part is formed of a perforated metal in which the fixing portions include holes regularly arranged at equal intervals in the X-axis direction and the Y-axis direction and forms a scale configured to obtain the arrangement position of the working unit with respect to the arrangement position of the robot , the second surface part is supported in parallel with the first surface part at a position higher than the first surface part in the Z-axis direction. a first surface part on which a robot that is configured to perform a work by performing a predetermined operation is arranged; a second surface part in which a plurality of fixing portions that are used to fix a working unit used in the work by the robot are provided at predetermined positions, and to which the working unit is fixed by using one or more fixing portions selected from the fixing portions , wherein the robot is configured to perform the work by using the working unit fixed to the second surface part and includes a sensor configured to detect a predetermined position of the second surface part , which position is associated with the plurality of fixing portions , and to perform the predetermined operation by using the detected predetermined position as a reference, the second surface part is formed of a perforated metal in which the fixing portions include holes regularly arranged at equal intervals in the X-axis direction and the Y-axis direction and forms a scale configured to obtain the arrangement position of the working unit with respect to the arrangement position of the robot , the second surface part is supported in parallel with the first surface part at a position higher than the first surface part in the Z-axis direction.
A digital display device comprising, from top to bottom, a first red filter , a transflective liquid crystal display cell , a second red filter and an emissive display cell , the transflective liquid crystal display cell displaying information by means of at least one first seven-segment digit and the emissive display cell comprising a plurality of juxtaposed light points which are arranged so as to display at least one second seven-segment digit .
Method for optically measuring at least the stability and the aggregation of particles in a liquid sample , which is in a sample container , wherein the method comprises the following steps: resting the sample container on a tempering element , wherein the sample container is tempered by means of a tempering element , irradiating the sample with light of at least a first wavelength , to fluorescently excite the particles, irradiating the sample with light of at least a second wavelength to examine the scattering of the particles, measuring the fluorescence light emitted by the sample ; and measuring the extinction light at the second wavelength, wherein the irradiated light of the second wavelength runs through the sample container , is reflected back, runs again through the sample container in opposite direction and exits as extinction light, wherein the stability is measured on the basis of the measured fluorescence light and the aggregation on the basis of the measured extinction light. resting the sample container on a tempering element , wherein the sample container is tempered by means of a tempering element , irradiating the sample with light of at least a first wavelength , to fluorescently excite the particles, irradiating the sample with light of at least a second wavelength to examine the scattering of the particles, measuring the fluorescence light emitted by the sample ; and measuring the extinction light at the second wavelength, wherein the irradiated light of the second wavelength runs through the sample container , is reflected back, runs again through the sample container in opposite direction and exits as extinction light, wherein the stability is measured on the basis of the measured fluorescence light and the aggregation on the basis of the measured extinction light.
An oral care composition for use in providing protection against erosion of tooth enamel comprising: (a) an orally acceptable vehicle; (b) a copolymer of a methylvinyl ether and a maleic anhydride; (c) zinc oxide; (d) an abrasive, and (e) a surfactant in an amount of 0.5-10% by weight, said surfactant comprising sodium lauryl sulfate.
A variable length headless compression screw insertion system comprising: - a compression screw having a bone screw and a compression sleeve coupled to the bone screw , wherein: the bone screw including a proximal end having an external threading threadably received in the compression sleeve , and the compression sleeve includes a proximal end having a predefined drive feature and an external threading; - a driver assembly for driving the compression screw into a bone and including: a sleeve coupler adapted to threadably receive the external threading of the compression sleeve ; a ram driver adapted to be coupled to the sleeve coupler and having a predetermined length such that its distal end is shaped to contact the proximal end of the bone screw to prevent translation of the bone screw relative to the compression sleeve ; - wherein the driver assembly further comprises a sleeve driver (120; 220) adapted to be coupled to the sleeve coupler and having a predetermined length such that its distal end has a complementary drive feature that mates with the predefined drive feature of the compression sleeve , the sleeve driver (120; 220) adapted to rotate the compression sleeve relative to the sleeve coupler ; and characterised in that - the compression sleeve includes a shaft having a first outer diameter and a drill tip extending from the shaft and having a second outer diameter larger than the first diameter. - a compression screw having a bone screw and a compression sleeve coupled to the bone screw , wherein: the bone screw including a proximal end having an external threading threadably received in the compression sleeve , and the compression sleeve includes a proximal end having a predefined drive feature and an external threading; - a driver assembly for driving the compression screw into a bone and including: a sleeve coupler adapted to threadably receive the external threading of the compression sleeve ; a ram driver adapted to be coupled to the sleeve coupler and having a predetermined length such that its distal end is shaped to contact the proximal end of the bone screw to prevent translation of the bone screw relative to the compression sleeve ; - wherein the driver assembly further comprises a sleeve driver (120; 220) adapted to be coupled to the sleeve coupler and having a predetermined length such that its distal end has a complementary drive feature that mates with the predefined drive feature of the compression sleeve , the sleeve driver (120; 220) adapted to rotate the compression sleeve relative to the sleeve coupler ; and characterised in that - the compression sleeve includes a shaft having a first outer diameter and a drill tip extending from the shaft and having a second outer diameter larger than the first diameter.
A method for evaluating cytokine release syndrome comprising: (a) engrafting an irradiated immunodeficient mouse with 1.5×10 7 - 3.0×10 7 human peripheral blood mononuclear cells (PBMCs), wherein the irradiated mouse has received irradiation to functionally suppress mouse immune cells; (b) administering to the irradiated immunodeficient mouse one or more immunomodulatory drugs 5-7 days following the engrafting of the human PBMCs; (c) detecting one or more cytokines in a sample from the mouse following the administering of the one or more immunomodulatory drugs; and (d) determining whether the immunomodulatory drug causes cytokine release syndrome. (a) engrafting an irradiated immunodeficient mouse with 1.5×10 7 - 3.0×10 7 human peripheral blood mononuclear cells (PBMCs), wherein the irradiated mouse has received irradiation to functionally suppress mouse immune cells; (b) administering to the irradiated immunodeficient mouse one or more immunomodulatory drugs 5-7 days following the engrafting of the human PBMCs; (c) detecting one or more cytokines in a sample from the mouse following the administering of the one or more immunomodulatory drugs; and (d) determining whether the immunomodulatory drug causes cytokine release syndrome.
Kit comprising a structure (1; 1') and a winch (10; 10') mounted thereon, the winch (10; 10') comprising a stator body , a rotor body rotatably mounted on the stator body , a gear group to command the angular movement of the rotor body with respect to the stator body , a base body (14; 14') distinct from the stator body and associated therewith, wherein the gear group is supported by the base body (14; 14') associated with the stator body , further comprising through holes formed in corresponding positions on the stator body and on the base body (14; 14'), for the passage of screws for the simultaneous attachment of the stator body and of the base body (14; 14') to the structure (1; 1'), characterised in that - before mounting the winch on the structure (1; 1') - the base body (14; 14') is irreversibly pre-assembled on the structure (1; 1').
Vibration device for stimulation of tissue in a nasal cavity of a patient, comprising: expandable stimulation means ; expansion means for expanding the stimulation means from a first, unexpanded state to a second, expanded state, wherein the expansion means comprises at least one channel for supplying fluid to the stimulation means to achieve said expansion, wherein the stimulation means is arranged partly around the expansion means such that one end of the expansion means is located inside the stimulation means, and an externally arranged vibration source arranged outside the stimulation means and connected to the expansion means, said vibration source being configured to bring the stimulation means to vibrate at a frequency of 30-70 Hz; wherein the stimulation means is configured, in the first, unexpanded state to be capable of being introduced via a nostril into the nasal cavity, and in the second, expanded state to be expanded to a volume such that the stimulation means abuts against the tissue within the nasal cavity. expandable stimulation means ; expansion means for expanding the stimulation means from a first, unexpanded state to a second, expanded state, wherein the expansion means comprises at least one channel for supplying fluid to the stimulation means to achieve said expansion, wherein the stimulation means is arranged partly around the expansion means such that one end of the expansion means is located inside the stimulation means, and an externally arranged vibration source arranged outside the stimulation means and connected to the expansion means, said vibration source being configured to bring the stimulation means to vibrate at a frequency of 30-70 Hz; wherein the stimulation means is configured, in the first, unexpanded state to be capable of being introduced via a nostril into the nasal cavity, and in the second, expanded state to be expanded to a volume such that the stimulation means abuts against the tissue within the nasal cavity.
Luggage-rack module for constructing a luggage rack in a rail vehicle, the luggage-rack module having a bearing panel , which can be fixed in relation to a bodyshell of the rail vehicle by means of at least one holder , having a rear supporting profile and having a front supporting member , characterized in that , at each of its two ends, the luggage-rack module has a holder , which is designed in the form of a bracket which is open in the downward direction, wherein the rear supporting profile is designed for attachment to the vehicle bodyshell, and the bearing panel extends over the entire length of the luggage-rack module and is retained in accommodating grooves of the holders , of the rear supporting profile and of the front supporting member .